|
negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I
|
GO_1904283 |
[Any process that stops, prevents or reduces the frequency, rate or extent of antigen processing and presentation of endogenous peptide antigen via MHC class I.] |
|
negative regulation of antigen processing and presentation of peptide antigen via MHC class I
|
GO_0002590 |
[Any process that stops, prevents, or reduces the frequency, rate, or extent of antigen processing and presentation of peptide antigen via MHC class I.] |
|
negative regulation of protein-pyridoxal-5-phosphate linkage
|
GO_1904286 |
[Any process that stops, prevents or reduces the frequency, rate or extent of protein-pyridoxal-5-phosphate linkage.] |
|
regulation of protein-pyridoxal-5-phosphate linkage
|
GO_1904285 |
[Any process that modulates the frequency, rate or extent of protein-pyridoxal-5-phosphate linkage.] |
|
lysosomal transport
|
GO_0007041 |
[The directed movement of substances into, out of or within a lysosome.] |
|
BAT3 complex binding
|
GO_1904288 |
[Binding to a BAT3 complex.] |
|
positive regulation of protein-pyridoxal-5-phosphate linkage
|
GO_1904287 |
[Any process that activates or increases the frequency, rate or extent of protein-pyridoxal-5-phosphate linkage.] |
|
lysosomal lumen acidification
|
GO_0007042 |
[Any process that reduces the pH of the lysosomal lumen, measured by the concentration of the hydrogen ion.] |
|
regulation of mitotic DNA damage checkpoint
|
GO_1904289 |
[Any process that modulates the frequency, rate or extent of mitotic DNA damage checkpoint.] |
|
GO_0007045
|
GO_0007045 |
|
|
cell-substrate junction organization
|
GO_0150115 |
[A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-substrate junction. A cell-substrate junction is a specialized region of connection between a cell and the extracellular matrix.] |
|
GO_0007047
|
GO_0007047 |
|
|
GO_0007046
|
GO_0007046 |
|
|
obsolete oncogenesis
|
GO_0007048 |
[OBSOLETE. (Was not defined before being made obsolete).] |
|
regulation of insulin receptor signaling pathway
|
GO_0046626 |
[Any process that modulates the frequency, rate or extent of insulin receptor signaling.] |
|
negative regulation of organ growth
|
GO_0046621 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of growth of an organ of an organism.] |
|
positive regulation of mitotic DNA damage checkpoint
|
GO_1904291 |
[Any process that activates or increases the frequency, rate or extent of mitotic DNA damage checkpoint.] |
|
sphingolipid floppase activity
|
GO_0046623 |
[Catalysis of the movement of a sphingolipid from the cytosolic to the exoplasmic leaflet of a membrane, using energy from the hydrolysis of ATP.] |
|
negative regulation of mitotic DNA damage checkpoint
|
GO_1904290 |
[Any process that stops, prevents or reduces the frequency, rate or extent of mitotic DNA damage checkpoint.] |
|
negative regulation of ERAD pathway
|
GO_1904293 |
[Any process that stops, prevents or reduces the frequency, rate or extent of ERAD pathway.] |